2 Red-Hot Biotech Stocks Squeezing Shorts

Both IOVA and MGNX reported upbeat cancer drug data

Patrick Martin

Managing Editor

May 16, 2019 at 10:18 AM

MGNX
IOVA

Two biotech stocks are making noise this morning on Wall Street. First, there's Iovance Biotherapeutics Inc (NASDAQ:IOVA), up 42.2% to trade at $15.63, one of the best stocks on the Nasdaq this morning, after the company reported upbeat cancer drug data at the annual American Society of Clinical Oncology (ASCO) meeting. Analyst Biren Amin at Jefferies called Iovance the "big winner" of the conference.

This is shaping up to be Iovance stock's best single-session gain since June 2016. The shares are trading at their highest point since a early September bear gap, and have now toppled their 320-day moving average; a trendline that turned away a rally back in April. IOVA has now more than doubled off its Dec. 21 bottom of $7.26.

A short squeeze could send IOVA closer to its Aug. 31 annual high of $18.25. Short interest dropped 7.9% in the most recent period to 9.80 million shares, the lowest since December. Yet this still accounts for 13.7% of the stock's total available float, and more than two weeks' worth of pent-up buying power, at its average pace of trading.

Also red-hot today is MacroGenics Inc (NASDAQ:MGNX), up 10.6% to trade at $18, after the company's late-stage study for Margetuximab, its breast cancer drug, met the first main goal. MacroGenics plans to file for U.S. approval in the second half of 2019.

Going into today, MacroGenics stock had only turned in one positive session in the last seven days. Since an annual high of $32.32 on Feb. 6, MGNX carved out a channel of lower lows, with its 40-day moving average keeping a lid on breakouts the last two months. Now, that trendline is set to be toppled, and the equity has extended its year-to-date lead to 28%.

Short sellers are likely not too thrilled about today's price action. Short interest increased by 13.6% in the two most recent reporting periods to 3.84 million shares. This represents a healthy 10.4% of the stock's total available float, and six times the average daily trading volume; plenty of fuel to squeeze shorts, should MGNX keep climbing.

Follow @Schaeffers

Two High-Octane Trade Ideas. One Simple Goal: Intraday Profits.

Dynamite Day Trading Signals delivers two same-day options trades every week — powered by proprietary intraday analysis and 43+ years of trading expertise.

But this isn’t just another stream of alerts.

It’s a structured plan with clear entry and exit points – designed for traders who want to act fast, trade smart, and wrap up gains before the closing bell.

No guesswork. No overnight exposure – Just two well-researched setups per week — whether you prefer buying premium or selling it.

And the results speak for themselves: subscribers have locked in +245.8% total profit over the last six months (since inception!).

👉 Start your one-month trial now for just $10, and be ready for the next trade alert.